These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

986 related items for PubMed ID: 26409014

  • 1. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S, WHO Study Group on Contraceptive Implants for Women.
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [Abstract] [Full Text] [Related]

  • 2. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D, WHO study group on subdermal contraceptive implants for women.
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [Abstract] [Full Text] [Related]

  • 3. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L, Brache V, Ali M, Habib N, WHO study group on contraceptive implants for women.
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
    Rowe P, Farley T, Peregoudov A, Piaggio G, Boccard S, Landoulsi S, Meirik O, IUD Research Group of the UNDP/UNFPA/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction.
    Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D, Briggs P, Tuppurainen M, Grunert J, Lukkari-Lax E, Rybowski S, Gemzell-Danielsson K.
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC, Riley HEM, Curtis KM.
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [Abstract] [Full Text] [Related]

  • 12. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF.
    Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.
    Lancet; 2019 Jul 27; 394(10195):303-313. PubMed ID: 31204114
    [Abstract] [Full Text] [Related]

  • 16. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, Biswas A, Viegas O, el din Abdalla K, Anant MP, Pavez M, Stern J.
    Hum Reprod; 1998 Dec 27; 13(12):3371-8. PubMed ID: 9886517
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T, Allonen H, Haukkamaa M, Holma P, Pyörälä T, Terho J, Toivonen J, Batar I, Lampe L, Andersson K.
    Contraception; 1987 Aug 27; 36(2):169-79. PubMed ID: 3123132
    [Abstract] [Full Text] [Related]

  • 19. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR, Lacarra M, McCarthy T, Holma P.
    Am J Obstet Gynecol; 1992 Apr 27; 166(4):1208-13. PubMed ID: 1566771
    [Abstract] [Full Text] [Related]

  • 20. Female sexual function in women using LARC methods.
    Trigo ACM, Maron CC, Pinheiro MSA, da Silva SBL, Brito MB.
    Gynecol Endocrinol; 2022 Jan 27; 38(1):68-72. PubMed ID: 34672861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.